BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6815988)

  • 1. [Evaluation of 9 months of treatment of lepromatous leprosy with desoxyfructo-serotonin].
    Saint-André P; Baquillon G; Mester de Parajd L; Mester de Parajd M
    Acta Leprol; 1982; (86-87):189-97. PubMed ID: 6815988
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of desoxyfructo-serotonin on Mycobacterium leprae. Results of inoculation of human biopsy specimens in the mouse after a year of treatment].
    Ferracci C; Baquillon G; Pattyn SR
    Acta Leprol; 1983; 1(4):233-5. PubMed ID: 6377799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desoxyfructo-serotonin: first human metabolite with antileprosy activity.
    Mester de Parajd L; Balakrishnan S
    Acta Leprol; 1981; (83):21-6. PubMed ID: 6792854
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and paraclinical evaluation of lepers at the Marchoux Institute after 12 months of treatment with desoxyfructo-serotonin].
    Baquillon G; Mester de Parajd L
    Acta Leprol; 1984; 2(1):65-8. PubMed ID: 6385601
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of leprosy by human metabolites].
    Mester de Parajd L; Mester de Parajd M
    Acta Leprol; 1986; 4(3):363-72. PubMed ID: 3105224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of deoxyfructoserotonin (DFS) on lepromatous leprosy.
    Antia NH; Ambrose EJ; Upleker MW; Mahadevan PR; Mester L
    Lancet; 1988 Mar; 1(8586):619-22. PubMed ID: 2894551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Desoxyfructo-serotonin: its therapeutic effect in the treatment of leprosy].
    Mester de Parajd M; Ambrose EJ; Tayeb N; Antia NH
    Acta Leprol; 1989; 7 Suppl 1():200-2. PubMed ID: 2503990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Update on the treatment of leprosy with desoxyfructo-serotonin at Bamako].
    Mester de Parajd L
    Acta Leprol; 1984; 2(1):69-70. PubMed ID: 6385602
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the incidence of type 2 reactions in lepromatous leprosy with two regimens of treatment.
    Manungo J; Thomas JE
    Cent Afr J Med; 1982 Sep; 28(9):209-11. PubMed ID: 7151141
    [No Abstract]   [Full Text] [Related]  

  • 10. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
    Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
    Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How should leprosy be treated?].
    Mahé A
    Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
    [No Abstract]   [Full Text] [Related]  

  • 13. Deoxyfructo-serotonin: a new drug with anti-leprosy activity.
    Mester de Parajd L; Balakrishnan S; Saint-André P; Mester de Parajd M
    Ann Microbiol (Paris); 1982; 133(3):427-32. PubMed ID: 7165215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of smear-positive cases treated with dapsone monotherapy.
    Naik SS; Shere SS
    Indian J Lepr; 1997; 69(2):196-7. PubMed ID: 9290975
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preliminary study on R 761 treatment for leprosy].
    Li WZ; Ye GY; Zhang YF; Feng B; Ma L; Ma BK; Jiang J; Gu SG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Oct; 4(5):293-5. PubMed ID: 6219765
    [No Abstract]   [Full Text] [Related]  

  • 16. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR; Pai VV; Samy MS; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract]   [Full Text] [Related]  

  • 17. Lepromatous leprosy.
    Booth AV; Kovich OI
    Dermatol Online J; 2007 Jan; 13(1):9. PubMed ID: 17511942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leprosy and HIV co-infection in five patients.
    Trindade MA; Manini MI; Masetti JH; Leite MA; Takahashi MD; Naafs B
    Lepr Rev; 2005 Jun; 76(2):162-6. PubMed ID: 16038250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal reaction and Mitsuda conversion in polar lepromatous leprosy: a case report.
    Kar BR; Job CK
    Lepr Rev; 2005 Sep; 76(3):258-62. PubMed ID: 16248213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Porichha D
    Indian J Lepr; 1998; 70(2):213-4; author reply 219-21. PubMed ID: 9724858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.